Skip to main content

Sarcoma

Protocols

Adult Soft Tissue Sarcoma

SAAI

Therapy for Advanced Soft Tissue Sarcoma Using DOXOrubicin, Ifosfamide-Mesna


SAAI3

3-day DOXOrubicin – ifosfamide - mesna for use in Patients with Advanced Soft Tissue Sarcoma


SAAJA

DOXOrubicin for Adjuvant Use for Patients with Non-Metastatic Operable Large High Grade Soft Tissue Sarcoma


SAAJADIC

Adjuvant Treatment of Patients with Soft Tissue Sarcoma using DOXOrubicin and Dacarbazine


SAAVA

Therapy for Advanced Soft Tissue Sarcoma Using DOXOrubicin


SAAVERIB

Palliative Therapy for Metastatic Sarcoma using eriBULin


SAAVGEMD

Therapy for Soft Tissue Sarcomas Using Gemcitabine and DOCEtaxel


SAAVI

Therapy for Advanced Soft Tissue Sarcoma Using Ifosfamide


SAAVI3

3-day Ifosfamide for Use in Patients with Advanced Soft Tissue Sarcoma


SAAVADIC

Treatment of Patients with Soft Tissue Sarcoma Using DOXOrubicin and Dacarbazine


SAAVTW

Metastatic or Unresectable Angiosarcoma using Weekly PACLitaxel (3 Weeks out of 4 Weeks Schedule)


SADTIC

High Dose Single Agent Dacarbazine (DTIC) for Metastatic Soft Tissue Sarcoma


SAHIPEC

Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Patients with Peritoneal Desmoplastic Small Round Cell Tumour (DSRCT) Using CISplatin


SATEMBEV

Therapy for Advanced Solitary Fibrous Tumours and Hemangiopericytoma Using Temozolomide and Bevacizumab

SAVDC

Adjuvant Therapy for Rhabdomyosarcoma Using vinCRIStine, Dactinomycin, and Cyclophosphamide

SAVDCM (deleted 01 Jan 2021)

Top


Gastrointestinal Stromal Cell Tumours (GIST)

SAAJGI

Adjuvant Treatment of C-Kit Positive High Risk Gastrointestinal Stromal Cell Tumours Using Imatinib


SAAVGI

Treatment of Advanced C-Kit Positive and C-Kit Negative Gastrointestinal Stromal Cell Tumours (GISTs) Using iMAtinib


SAAVGIDD

Treatment of Advanced c-Kit Positive Gastrointestinal Stromal Cell Tumours (GISTs) Using 800 mg Dosing of imatinib


SAAVGR

Third Line Treatment of Advanced Gastrointestinal Stromal Cell Tumours (GISTs) Using Regorafenib


SAAVGRIP

Fourth-Line Therapy of Advanced Gastrointestinal Stromal Cell Tumours (GIST) using Ripretinib


SAAVGS

Second Line Treatment of Advanced C-Kit Positive Gastrointestinal Stromal Cell Tumours (GISTs) After Imatinib Using Sunitinib

Top


Osteosarcoma

SAAJAP

Adjuvant Therapy for Osteosarcoma Using DOXOrubicin and CISplatin


SAAVAP

Therapy of Advanced Osteosarcoma Using DOXOrubicin and CISplatin


SAAVOR

Treatment of Relapsed or Refractory Advanced Osteosarcoma using Regorafenib


SAHDMTX (deleted 01 May 2021)

Top

Fibromatosis

SAMV

Palliative Therapy for Aggressive Fibromatosis Using Weekly or Alternate Week Methotrexate and vinBLAstine Intravenously


SATAM

Therapy for Recurrent Desmoid Tumours/Aggressive Fibromatosis Using Tamoxifen

Top


Pediatric Sarcomas & Post-Pediatric Disease

SAALT2W

Etoposide, Ifosfamide-Mesna (SAIME) Alternating with vinCRIStine, DOXOrubicin and Cyclophosphamide (with or without Mesna)(SAVAC or SAVACM) with Filgrastim Support at TWO Weekly Intervals for Newly Diagnosed Ewing's Sarcoma/ Ewing’s Family of Tumours, Desmoplastic Intra-abdominal Small Round Blue Cell tumour or Rhabdomyosarcoma


SAALT3W

Etoposide, Ifosfamide-Mesna (SAIME) Alternating with vinCRIStine, DOXOrubicin and Cyclophosphamide (with or without Mesna)(SAVAC or SAVACM) with Filgrastim Support at THREE Weekly Intervals for Newly Diagnosed Ewing's Sarcoma/ Ewing’s Family of Tumours, Desmoplastic Intra-abdominal Small Round Blue Cell tumour or Rhabdomyosarcoma


SAAVIME3

3-Day Etoposide & Ifosfamide-Mesna for Patients with Advanced Soft Tissue or Bony Sarcomas

SAAVTC

Treatment of Recurrent/refractory Neuroblastoma, Ewing's Sarcoma, Osteogenic Sarcoma or Rhabdomyosarcoma with Topotecan/Cyclophosphamide


SAIME

Etoposide, Ifosfamide-Mesna (SAIME) for Use in Sarcomas


SAVAC

Treatment of Sarcomas with vinCRIStine, DOXOrubicin and Cyclophosphamide (SAVAC)


SAVACM

Treatment of Sarcomas with Pelvic Primaries or Chemotherapy Induced Hematuria Using vinCRIStine, DOXOrubicin, Cyclophosphamide and Mesna

Top


Kaposi Sarcoma

KSLDO

Therapy of Kaposi Sarcoma Using DOXOrubicin Pegylated Liposomal (CAELYX)

Top


KSVB

Therapy for Kaposi Sarcoma Using vinBLAstine-vinCRIstine


Other

SANADENO

Denosumab for Neoadjuvant Use in Patients with Non-Metastatic Operable Giant Cell Tumour of the Bone

Top

Funding Algorithm

The funding algorithm provides information on what anti-cancer systemic therapy treatments are covered on the BC Cancer Benefit Drug List (formulary). It may not be a complete list of all treatment options that may be available and recommended by the treating physician.
Terms of use

The information contained in these documents is a statement of consensus of BC Cancer professionals regarding their views of currently accepted approaches to treatment. Any clinician seeking to apply or consult these documents is expected to use independent medical judgement in the context of individual clinical circumstances to determine any patient's care or treatment. Use of these documents is at your own risk and is subject to BC Cancer's Terms of Use.

Tab Heading
SOURCE: Sarcoma ( )
Page printed: . Unofficial document if printed. Please refer to SOURCE for latest information.

Copyright © BC Cancer. All Rights Reserved.

    Copyright © 2024 Provincial Health Services Authority